Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases
Peter J O’Brien1, Rajeev Ramanathan2, Jonathan M Yingling1, Jose Baselga3, Mace L Rothenberg4, Michael Carducci5, Thomas Daly1, Dorothy Adcock2, Michael Lahn11Eli Lilly and Company Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA; 2Esoterix Coagulation, Aurora, CO,...
Guardado en:
Autores principales: | Peter J O’Brien, Rajeev Ramanathan, Jonathan M Yingling, Jose Baselga, Mace L Rothenberg, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb6a465b749d4abc800f350f26a9a6fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Role of TGF-β in Bone Metastases
por: Trupti Trivedi, et al.
Publicado: (2021) -
An update on the toxicity of Aβ in Alzheimer’s disease
por: Jürgen Götz, et al.
Publicado: (2008) -
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
por: Sun-Ho Han, et al.
Publicado: (2010) -
Effect of 17β-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats
por: Inmaculada Tasset, et al.
Publicado: (2008) -
Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
por: Stopeck AT, et al.
Publicado: (2012)